Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01577433 · ClinicalTrials.gov registry record
Driveline Silicone Skin Interface Registry
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 400
- Enrollment target
NCT01577433: Completed study, sponsored by Abbott Medical Devices.
NCT01577433 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01577433 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
The purpose of this observational registry is to determine the freedom from driveline (DL) infection events in subjects implanted with a HeartMate II LVAD in whom only the silicone portion of the DL is externalized resulting in a silicone skin interface (SSI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2012-05 |
| Est. Completion | 2018-12 |
What the finished NCT01577433 record still lists
NCT01577433 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01577433 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01577433 about?
NCT01577433 is a clinical study titled "Driveline Silicone Skin Interface Registry". The purpose of this observational registry is to determine the freedom from driveline (DL) infection events in subjects implanted with a HeartMate II LVAD in whom only the silicone portion of the DL is externalized resulting in a silicone skin interface (SSI)
What is the current status of trial NCT01577433?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2012-05. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT01577433?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia